Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page footer shows Revision: v3.6.3, replacing v3.6.2, indicating a small maintenance update to the site.SummaryDifference0.1%

- Check16 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a platform/template update that affects the page wrapper rather than study information.SummaryDifference0.1%

- Check30 days agoChange DetectedThe study page now indicates that it is no longer recruiting participants, signaling that enrollment is closed. New navigation and guidance sections such as How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment heading were added, reflecting a reorganization and improved user guidance.SummaryDifference0.5%

- Check37 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, reflecting a small update to the page's content.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a maintenance update to the document or site component. This reflects an internal change rather than an alteration to user-facing content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page shows a revision tag updated to v3.5.3, replacing the previous v3.5.2. This reflects a minor update to the ClinicalTrials.gov entry without altering core study information.SummaryDifference0.1%

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.